Physician profile
Mark G Kent
NPI 1285783274
$2,115.18
in general payments reported to CMS, 2019-2025
14 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $62.05 · 2022: $1,065 · 2023: $25.64 · 2024: $189 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483 · Travel and Lodging: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.84 |
| Travel and Lodging | $174.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,118.14 | 2019-2024 | Renasys Touch, Grafix Pl |
| Intuitive Surgical, INC. | $404.42 | 2019-2025 | |
| Davol INC. | $148.05 | 2024 | Arista Ah Flexitip |
| Teleflex LLC | $126.92 | 2019-2025 | Arrow |
| Ethicon US, LLC | $116.26 | 2019 | |
| Baxter Healthcare | $39.50 | 2025 | Tisseel |
| Innovation Technologies INC | $35.14 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $34.28 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.64 | 2023 | Lifevest |
| Leica Microsystems INC. | $16.45 | 2019 | |
| Focal Therapeutics, INC. | $14.33 | 2020 | |
| Kci USA, INC. | $13.23 | 2020 | |
| Endo Pharmaceuticals INC. | $12.71 | 2020 | |
| Medela LLC | $10.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.